Using a combination of DPP-4 inhibitors, a second and/or a third type of diabetic formulation can be selected for therapeutic purposes from gloves, endosulfan, fipronil, glycerin, alpha-glucose inhibitors a, GLP-1 and insulin. Or type 2 diabetes.

摘要

Composition or Pharmaceutical Combination comprising (a) a dpp-4 inhibitor and Optionally, (b) a Second diabetic agent which consists of Thiazolidinediones, sulfonylureas, Biguanides, among others.And (c) a Third Agent diabetic; method to prevent or treat a disorder such as diabetes mellitus Type 1 or 2, among others.